Overall, the addition of oral semaglutide 7 mg or 14 mg compared favorably to the addition of sitagliptin 100 mg in patients with T2DM inadequately controlled on metformin sulfonylurea background therapy
Once available, users will likely attach a small disposable needle to the pen before injection
Early research and growing examples suggest that addressing both hormonal decline with MHT and metabolic changes with GLP-1 therapy could result in greater weight loss and metabolic improvements compared to either approach alone
*Oral Diseases*, 22(6), 463-493
(PubMed) Cherchi A, Lai C, Angelino F, et al
For patients with diabetes, blood sugar control often takes priority